AbbVie Inc.’s pricing practices for some of its top-selling medicines faced fresh scrutiny from federal lawmakers Tuesday, the latest effort by members of Congress probing the cost of prescription drugs.
After months of small incremental steps towards reopening, New York is seeing the rapid-fire lifting of pandemic related restrictions this week, and the end of staunch safety regulations that have come to define the “new normal” since March 2020.